Related Experiment Video
Updated: May 24, 2026

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
Published on: October 28, 2020
Left-sided ventricular cardiomyopathy with minimal right ventricular involvement
1Department of Forensic Medicine, University of Peradeniya, Sri Lanka. kaskodikara@yahoo.com
Insights
Arrhythmogenic cardiomyopathy, typically affecting the right ventricle, can rarely present with predominant left ventricular involvement. This case highlights a fatal instance of left ventricular arrhythmogenic cardiomyopathy with minimal right ventricular impact.
Area of Science:
- Cardiology
- Pathology
- Genetics
Background:
- Arrhythmogenic cardiomyopathy (ACM) is a rare heart muscle disease.
- It is characterized by fibro-fatty replacement of cardiomyocytes.
- ACM primarily affects the right ventricle (RV), leading to arrhythmias and sudden cardiac death.
Observation:
- A previously healthy 31-year-old male presented with sudden death.
- Autopsy revealed an enlarged heart with asymmetrical left ventricular (LV) hypertrophy.
- LV myocardium showed significant epicardial and intramyocardial fibro-fatty infiltration, predominantly fatty.
Findings:
- The LV variant of arrhythmogenic cardiomyopathy was diagnosed.
- Minimal fibro-fatty infiltration was observed in the RV.
- No evidence of ischemic changes or significant myofiber disarray was found.
Implications:
- This case underscores the rare occurrence of arrhythmogenic cardiomyopathy predominantly affecting the left ventricle with minimal RV involvement.
- Further research is needed to understand the full spectrum and etiology of this LV variant.
- Highlights the importance of considering atypical presentations of ACM in sudden cardiac death investigations.
Abstract:
Left-sided ventricular arrhythmogenic cardiomyopathy is rare and represents a rather different expression of the arrhythmogenic right ventricular (RV) cardiomyopathy (ARVC). Among sudden cardiac deaths, ARVC plays a significant role. ARVC is considered as a cardiomyopathy of unknown aetiology that primarily involves the right ventricle (RV) and is characterized by progressive replacement of myocytes by fibro-fatty tissue, complicating a spectrum of arrhythmias. Predominant ARVC with left ventricular (LV) involvement is also reported. The LV variant of arrhythmogenic cardiomyopathy with minimal or no RV involvement is rare. A 31-year-old previously healthy young man, without a significant family history, was found dead in bed. Autopsy revealed an enlarged heart and asymmetrical LV hypertrophy with widely patent coronary arteries. LV myocardium demonstrated evidence of prominent epicardial fibro-fatty tissue that is predominantly fatty in nature and infiltrates into the myocardium. Microscopy of the LV free wall showed fibro-fatty tissue infiltration into the epicardial aspect of the LV that extends well into the mid-myocardium. A moderate to marked degree of interstitial fibrous tissue deposition was noted about adipocytes and cardiomyocytes. There was no evidence of chronic ischaemic changes or of significant myofibre disarray. The RV showed minimal fibro-fatty infiltration with normal myocytes. This report highlights a rare case which confirms previous observations that the LV variant of arrhythmogenic cardiomyopathy could occur with minimal or no involvement of the RV. Further studies are required in this context to elicit the spectrum and the exact nature of this disease.
More Related Videos
10:18Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
Published on: February 1, 2022
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Mitral Regurgitation I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care